Homocysteine and serotonin: association with postpartum depression
S Aishwarya1, Soundravally Rajendiren, Shivanand Kattimani
1Department of Biochemistry, JIPMER, Puducherry 605006, India.
Insights
Elevated homocysteine levels are linked to postpartum depression (PPD) and lower infant APGAR scores. Nutritional status, particularly homocysteine metabolism, is crucial for maternal mental health and infant development.
Area of Science:
- Neuroscience
- Biochemistry
- Perinatal Medicine
Background:
- Postpartum depression (PPD) has multifactorial origins, impacting maternal and child health.
- Perturbed methionine-homocysteine metabolism is implicated, potentially affecting nerve fiber myelination and child development.
Purpose of the Study:
- To investigate the association between homocysteine, vitamin B12, folic acid, and serotonin levels and PPD.
- To assess the impact of maternal PPD on infant well-being via APGAR scores.
Main Methods:
- 103 women (58 with PPD, 45 without) were studied.
- PPD assessed using Edinburgh postnatal depression scale; fetal well-being by APGAR score.
- Serum levels of folic acid, vitamin B12, homocysteine, and serotonin measured via ELISA.
Main Results:
- Significantly elevated homocysteine levels found in women with PPD at 24-48h and six weeks postpartum.
- No association found between PPD and folate or vitamin B12 levels.
- Negative correlation between serum homocysteine and serotonin in the PPD group; lower APGAR scores in infants of mothers with PPD.
Conclusions:
- Homocysteinemia is associated with PPD at both early and later postpartum stages.
- Low serum serotonin may contribute to early PPD, but its role diminishes by six weeks.
- Maternal PPD is linked to lower infant APGAR scores, highlighting the importance of maternal mental and nutritional health.
Abstract:
Postpartum depression (PPD) is a disorder of multifactorial origin with significant consequences on both maternal and child health. One of the biological factors implicated is perturbed methionine-homocysteine metabolism. Since this metabolic pathway plays a significant role in myelination of nerve fibers, the growth and development of the child would also be adversely affected. We carried out this study in 103 women (58 with PPD and 45 without PPD) who delivered their child in our institute from December 2010 to November 2011. The study group was evaluated for PPD using Edinburgh postnatal depression scale with a cut-off score of 10. Assessment of fetal well being was done by APGAR score assessed immediately after birth. Serum folic acid, vitamin B12, homocysteine and serotonin was done by ELISA. We found significantly elevated levels of homocysteine in women with PPD as compared to those without PPD, both at 24-48h as well as six weeks after delivery, although no associations were found with folate and vitamin B12 levels. Also, there was a significant negative correlation between serum homocysteine and serotonin levels in the postpartum depression group with a significant negative correlation between homocysteine and serotonin. Our study showed a significantly lower APGAR score in the infants born to mothers with PPD. Our study also shows that homocysteinemia is associated with PPD whether at the first week or sixth week, while low serum serotonin may play a role in depression during the first week, but may not have a role in depression status at the sixth week. Also, PPD in the mother is related to a low APGAR score in infants born to these mothers emphasizing the significance of both mental as well as nutritional status of the mother.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
G-protein Coupled Receptors
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Psychological and Sociocultural Causes of Schizophrenia
Antidepressant Drugs: MAOIs and Other Agents


